Pure Global

Rapid test for detection of Antibodies to Syphilis in Human Serum/ Plasma/ Whole Blood - India CDSCO Medical Device Registration

Rapid test for detection of Antibodies to Syphilis in Human Serum/ Plasma/ Whole Blood is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000085_c52d2642c69a8f47e616cde955b7ba03_c52d2642c69a8f47e616cde955b7ba03. This device is marketed under the brand name Rapid Plasma Reagin. The license holder is Voxtur Bio Ltd, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Rapid test for detection of Antibodies to Syphilis in Human Serum/ Plasma/ Whole Blood
UID: MFG/IVD/2022/000085_c52d2642c69a8f47e616cde955b7ba03_c52d2642c69a8f47e616cde955b7ba03

Brand Name

Rapid Plasma Reagin

License Holder

Voxtur Bio Ltd

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

Rapid test for detection of Antibodies to Syphilis in Human Serum/ Plasma/ Whole Blood

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing